Dermatology Times Staff

In October, the Food and Drug Administratin is expected to decide on the approval of omadacycline (Paratek Pharmaceuticals) for the treatment of acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.

In this slideshow, we highlight some of this year's clinical advances in psoriasis and plaque psoriasis.

The European Academy of Dermatology and Venerology (EADV) 2018 meeting takes this week in Paris. Visit our EADV conference news site to follow the developments from Paris.

The September 2018 issue of Dermatology Times includes a special supplment on treating acne scarring. It highlights some of the latest advances in treating patients who suffer from this condition.

A 52-year-old man presents with a severe headache and widespread rash after a camping trip. What's your diagnosis?

Survey offers insights on the future of healthcare costs - and your role as providers

This month we feature new products from MiraDry, Qosmedix, Rekze and Syneron Candela for conditions ranging from underarm sweating to rosacea and cellulite.

The August issue of Dermatology Times includes a supplement edition that focuses on a patient-centered approach in psoriasis management, including an article on the importance of longer consults in the doctor's office and recommendations for individualized therapy. Read more here.  

A Johns Hopkins study finds that physicians who use stigmatizing language in their patients' medical records, may actually be hurting the care those patients get for years to come.

In June, the European Commission approved tofacitinib citrate (Xeljanz/Pfizer) 5 mg twice daily in combination with methotrexate for adults with psoriatic arthritis. Learn about the parameters here.

In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.

The July issue of Dermatology Times highlights some newly approved treatments in dermatology including a new wrinkle filler and new treatment for seborrheic keratosis.

From the July issue of Dermatology Times, new products for dermatologists and patients.

There are four questions physicians should ask when considering using digital healthcare technologies, says Michael L. Hodgkins, M.D., chief medical officer for the American Medical Association. View the slideshow for more information.

Diet can affect skin conditions including acne, atopic dermatitis, psoriasis and rosacea. In a review that focuses on these four conditions, plus aging, Rajani Katta, M.D., and Mary Jo Kramer, B.S., writing in Skin Therapy Letter, highlight trigger foods that should be avoided.

For some patients with moderate to severe atopic dermatitis, the combination of dupilumab and corticosteroids may be necessary to control flares, a new study shows. Dupilumab is a proven treatment for AD, so where do we go from here? A physician writing in BJD suggests predictive modeling.

Publishing new research findings certainly has its benefits, but how physicians use that information and their personal experience in clinical practice can prove to be more insightful. In this article, we feature three physicians who participated in the rapid-fire Q&A “60 Tips in 60 Minutes” from the Winter Clinical Dermatology Conference held in January in Hawaii.

In a comparison of the performance between physician assistants and dermatologists, physician assistants may have lower diagnostic accuracy for melanoma than dermatologists, suggests a study published in JAMA Dermatology. The AAPA and SDPA question the use of the NNB ratio to determine diagnostic accuracy.

Publishing new research findings has its benefits, but how physicians use that information and their personal experience in clinical practice can prove to be more insightful. In this table on page 98 of Dermatology Times June issue, we feature insights from three physicians who participated in the rapid-fire Q&A “60 Tips in 60 Minutes” from this year's Winter Clinical Dermatology Conference.

Laser technology may be one of the most important purchases for a dermatology practice. Anne Chapas, M.D., of Union Square Laser Dermatology in New York, suggests that physicians do their research before making such an important investment. “I’ve actually seen people go bankrupt because they didn’t know how to use this very expensive laser that they purchased,” she said. Dr. Chapas suggests the following considerations before making your first purchase.

It’s time for our annual survey and we need your input to ensure that we’re meeting your information needs. Please take five minutes to complete the Dermatology Times reader survey.

The U.S. Food and Drug Administration issued a draft guidance in March proposing to regulate medicines that are produced in bulk by compounding pharmacies.

“As we move toward finding a cure for psoriasis, what we are looking for are high performance drugs that provide durable response in between treatments and that lend themselves to patient compliance,” says Dr. George Martin.

A small study shows that ultrasound may be a viable diagnostic tool to determine whether patients have psoriasis or psoriatic arthritis, Italian researchers report.

New data and status updates for atopic dermatitis treatments in clinical trials will be presented at the American Academy of Dermatology annual meeting in San Diego this week. In this article, we offer some highlights.

NEJM analysis proves what has been suspected for decades: Alcohol can be more deadly in the psoriasis population as compared to non-psoriasis patients.

In this slideshow, we highlight some industry developments from 2017 and offer a snapshot of what the New Year may hold, such as an increased demand for tele-dermatology, topical scar treatments, silicon-based scar treatments and hair transplantation services.

The latest roundup of new dermatology products includes safe ultrasound treatment in the home, skincare for aging skin, and topical pain relief.